{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 10.544031143188477, "B": 9.73742961883545, "C": 11.016551971435547, "D": 10.772361755371094, "E": 10.256062507629395}, "ranked_options": [{"letter": "B", "text": "Rituximab", "avg_nll": 9.73742961883545}, {"letter": "E", "text": "Doxorubicin", "avg_nll": 10.256062507629395}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 10.544031143188477}, {"letter": "D", "text": "Vincristine", "avg_nll": 10.772361755371094}, {"letter": "C", "text": "Cyclophosphamide", "avg_nll": 11.016551971435547}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 8.210488319396973, "B": 8.830900192260742, "C": 8.828561782836914, "D": 8.063474655151367, "E": 8.342018127441406}, "ranked_options": [{"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 8.063474655151367}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 8.210488319396973}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 8.342018127441406}, {"letter": "C", "text": "She has a mood disorder.", "avg_nll": 8.828561782836914}, {"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 8.830900192260742}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 10.0283784866333, "B": 7.9974822998046875, "C": 11.104989051818848, "D": 10.164966583251953, "E": 10.660062789916992}, "ranked_options": [{"letter": "B", "text": "Dementia", "avg_nll": 7.9974822998046875}, {"letter": "A", "text": "Multiple sclerosis", "avg_nll": 10.0283784866333}, {"letter": "D", "text": "Brain abscess", "avg_nll": 10.164966583251953}, {"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 10.660062789916992}, {"letter": "C", "text": "Parkinson", "avg_nll": 11.104989051818848}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 7.191808223724365, "B": 7.599242210388184, "C": 7.2106146812438965, "D": 7.739778995513916, "E": 7.3323822021484375}, "ranked_options": [{"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 7.191808223724365}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 7.2106146812438965}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 7.3323822021484375}, {"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 7.599242210388184}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 7.739778995513916}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 7.458183288574219, "B": 7.770296573638916, "C": 7.746129035949707, "D": 7.694348335266113, "E": 8.236784934997559}, "ranked_options": [{"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 7.458183288574219}, {"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 7.694348335266113}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 7.746129035949707}, {"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 7.770296573638916}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 8.236784934997559}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 9.719925880432129, "B": 9.702069282531738, "C": 9.216962814331055, "D": 9.328290939331055, "E": 9.320478439331055}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 9.216962814331055}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 9.320478439331055}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 9.328290939331055}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 9.702069282531738}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 9.719925880432129}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 8.517772674560547, "B": 7.061513423919678, "C": 8.000134468078613, "D": 9.53732681274414, "E": 8.01257038116455}, "ranked_options": [{"letter": "B", "text": "Imeron 400", "avg_nll": 7.061513423919678}, {"letter": "C", "text": "Optiray 320", "avg_nll": 8.000134468078613}, {"letter": "E", "text": "Xenetix 350", "avg_nll": 8.01257038116455}, {"letter": "A", "text": "Omnipaque 320", "avg_nll": 8.517772674560547}, {"letter": "D", "text": "Gadovist", "avg_nll": 9.53732681274414}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 9.18740463256836, "B": 8.8814058303833, "C": 9.454758644104004, "D": 9.310455322265625, "E": 9.3286714553833}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 8.8814058303833}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 9.18740463256836}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 9.310455322265625}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 9.3286714553833}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 9.454758644104004}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 8.465887069702148, "B": 7.293889045715332, "C": 7.496302127838135, "D": 8.604248046875, "E": 7.98541259765625}, "ranked_options": [{"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 7.293889045715332}, {"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 7.496302127838135}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 7.98541259765625}, {"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 8.465887069702148}, {"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 8.604248046875}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 8.964468002319336, "B": 8.88075065612793, "C": 8.857169151306152, "D": 8.548563003540039, "E": 8.856270790100098}, "ranked_options": [{"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 8.548563003540039}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 8.856270790100098}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 8.857169151306152}, {"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 8.88075065612793}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 8.964468002319336}], "correct_answer_letter": "B", "error": null, "method": "local"}
